Literature DB >> 32905970

The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis.

Amirhossein Davoodvandi1, Maryam Darvish2, Sarina Borran3, Majid Nejati4, Samaneh Mazaheri5, Omid Reza Tamtaji6, Micheal R Hamblin7, Nahid Masoudian8, Hamed Mirzaei9.   

Abstract

Resveratrol is an anticancer phytochemical polyphenol isolated from a natural origin, without any significant side effects. Resveratrol was investigated in immunocompetent mice with regards to its possible effect on lung cancer metastasis. Cytotoxicity was assessed in three melanoma cell lines (B16F10, B6, and A375) by administration of 20 and 40 μM resveratrol. B16F10 cells were transfected with pT-tdTomato vector to express red fluorescent protein (RFP). RFP-B16F10 cells were injected IV into 3 groups of 20 C57BL/6 mice (ten for tests and others for survival). The three groups include PBS, no treatment, and resveratrol 40 mg/kg IP (4X/week for 3 weeks). Lung tissues were analyzed by TUNEL assay, Western blot, and immunohistochemistry. The in vitro growth of all melanoma cell lines was significantly suppressed by 40 μM resveratrol for 3 days. The mean survival rate of mice was enhanced and the lung tumor growth was inhibited by in vivo IP injection of 40 mg/kg resveratrol. Increased CXCL10 and IFN-γ levels and decreased angiogenesis and less tumor infiltration by Tregs were found in the lung tumors. In conclusion, lung metastasis of melanoma was effectively inhibited by resveratrol treatment.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung metastases; Melanoma; Mouse model; Resveratrol

Mesh:

Substances:

Year:  2020        PMID: 32905970     DOI: 10.1016/j.intimp.2020.106905

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

Review 1.  Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy.

Authors:  Magdalena Jurczyk; Janusz Kasperczyk; Dorota Wrześniok; Artur Beberok; Katarzyna Jelonek
Journal:  Biomedicines       Date:  2022-05-20

2.  NEAT1 in bone marrow mesenchymal stem cell-derived extracellular vesicles promotes melanoma by inducing M2 macrophage polarization.

Authors:  Yemei Yang; Shengfang Ma; Zi Ye; Yushi Zheng; Zhenjiong Zheng; Xiongshan Liu; Xianyi Zhou
Journal:  Cancer Gene Ther       Date:  2022-02-03       Impact factor: 5.854

3.  A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment.

Authors:  Anna Lantsova; Irina Golubeva; Larisa Borisova; Lyudmila Nikolaeva; Lydia Ektova; Maria Dmitrieva; Olga Orlova
Journal:  BMC Complement Med Ther       Date:  2021-04-10

Review 4.  Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.

Authors:  Maryam Fallah; Amirhossein Davoodvandi; Shahin Nikmanzar; Sarehnaz Aghili; Seyed Mohammad Ali Mirazimi; Michael Aschner; Amir Rashidian; Michael R Hamblin; Mohsen Chamanara; Navid Naghsh; Hamed Mirzaei
Journal:  Biomed Pharmacother       Date:  2021-08-13       Impact factor: 6.529

5.  Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.

Authors:  Omchit Surien; Ahmad Rohi Ghazali; Siti Fathiah Masre
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

Review 6.  Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment.

Authors:  Gagan Chhabra; Chandra K Singh; Deeba Amiri; Neha Akula; Nihal Ahmad
Journal:  Molecules       Date:  2021-03-03       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.